Bioorthogonal Engineered Virus-Like Nanoparticles for Efficient Gene Therapy

Area of Science:

• Biotechnology
• Nanomedicine
• Gene Therapy

Background:

• Gene therapy faces challenges in targeted tissue delivery.
• Developing safe and effective gene delivery vectors is crucial for treating diseases.

Purpose of the Study:

• To develop a novel virus-like nanoparticle, reBiosome, for efficient gene therapy.
• To evaluate reBiosome's efficacy in treating cancer and inflammatory diseases.

Main Methods:

• Engineered mutant virus-like biosomes (mBiosomes) displaying 4-azido-L-phenylalanine.
• Bioorthogonal chemistry to attach weak acid-responsive polymers, creating reBiosomes.
• In vivo studies in breast cancer and arthritis models.

Main Results:

• reBiosome demonstrated reduced immunogenicity and prolonged blood circulation.
• Enhanced gene delivery to weakly acidic tumor and arthritic tissues.
• Robust therapeutic efficacy in preclinical cancer and arthritis models.

Conclusions:

• reBiosome is a safe and efficient platform for gene therapies.
• This nanoparticle technology holds promise for treating cancer and inflammatory diseases.
• The study presents a universal platform for advanced gene delivery applications.